Amelia Bartholomew
Overview
Explore the profile of Amelia Bartholomew including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1687
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
LaStayo P, McDonagh P, Lipovic D, Napoles P, Bartholomew A, Esser K, et al.
J Geriatr Phys Ther
. 2008 Jan;
30(3):128-34.
PMID: 18171497
Background And Purpose: Elderly individuals participate in resistance exercise to induce an anabolic response and grow muscle to help overcome functional deficits. It is thought that a muscle damage and...
22.
Sudan D, Bacha E, John E, Bartholomew A
Pediatr Rev
. 2007 Dec;
28(12):439-53.
PMID: 18055642
No abstract available.
23.
Kaput J, Perlina A, Hatipoglu B, Bartholomew A, Nikolsky Y
Pharmacogenomics
. 2007 Mar;
8(4):369-90.
PMID: 17391074
The maintenance of health and the prevention and treatment of chronic diseases are influenced by naturally occurring chemicals in foods. In addition to supplying the substrates for producing energy, a...
24.
Kaput J, Noble J, Hatipoglu B, Kohrs K, Dawson K, Bartholomew A
Nutr Metab Cardiovasc Dis
. 2007 Feb;
17(2):89-103.
PMID: 17276047
The genetic makeup that individuals inherit from their ancestors is responsible for variation in responses to food and susceptibility to chronic diseases such as Type 2 diabetes mellitus (T2DM). Common...
25.
Beggs K, Lyubimov A, Borneman J, Bartholomew A, Moseley A, Dodds R, et al.
Cell Transplant
. 2007 Feb;
15(8-9):711-21.
PMID: 17269442
Mesenchymal stem cells (MSCs) express low immunogenicity and demonstrate immunomodulatory properties in vitro that may safely allow their transplantation into unrelated immunocompetent recipients without the use of pharmacologic immunosuppression. To...
26.
Moadsiri A, Polchert D, Genrich K, Napoles P, Reina E, Turian J, et al.
Surgery
. 2006 Aug;
140(2):315-21.
PMID: 16904985
Background: Xenogeneic hematopoietic engraftment holds promise as a strategy to achieve whole organ xenograft tolerance. We tested whether xenogeneic bone marrow grafts, engineered with mesenchymal stem cells (MSCs), might provide...
27.
Kaput J, Ordovas J, Ferguson L, van Ommen B, Rodriguez R, Allen L, et al.
Br J Nutr
. 2005 Nov;
94(5):623-32.
PMID: 16277761
Nutrigenomics is the study of how constituents of the diet interact with genes, and their products, to alter phenotype and, conversely, how genes and their products metabolise these constituents into...
28.
Mahmud N, Pang W, Cobbs C, Alur P, Borneman J, Dodds R, et al.
Exp Hematol
. 2004 May;
32(5):494-501.
PMID: 15145218
Objective: The aim of this study was to examine the effects of the route of administration [intrabone marrow (IBM) vs intravenous (IV)] and the role of conditioning with irradiation in...
29.
Devine S, Cobbs C, Jennings M, Bartholomew A, Hoffman R
Blood
. 2002 Dec;
101(8):2999-3001.
PMID: 12480709
Ex vivo-expanded mesenchymal stem cells (MSCs) were transduced with a green fluorescent protein (GFP) retroviral construct and subsequently infused into 3 adult baboons following lethal total body irradiation and hematopoietic...
30.
Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al.
Exp Hematol
. 2002 Feb;
30(1):42-8.
PMID: 11823036
Objective: Mesenchymal stem cells (MSCs), multipotential cells that reside within the bone marrow, can be induced to differentiate into various components of the marrow microenvironment, such as bone, adipose, and...